SARS-COV-2

ACEGID Supports Pubic Health Authorities with Evidence

ACEGID works with national, regional and international public health authorities on outbreak response. Using genomics data that are presented in interactive and engaging forms, we provide evidence to inform policy formulation, implementation and review. For example, ACEGID generated and shared genomics data that guided the Nigerian Centre for Disease Control’s policies. The centre’s collaboration with …

ACEGID Supports Pubic Health Authorities with Evidence Read More »

ACEGID Trains 100+ Scientists from Over 30 African Countries in One Year

In the last year, the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) has trained over 100 African scientists from more than 30 countries in next-generation sequencing of SARS-CoV-2 (the virus that causes Covid-19) and other pathogens. This is part of the centre’s effort at building genomics capacity across Africa. The workshops held …

ACEGID Trains 100+ Scientists from Over 30 African Countries in One Year Read More »

Recruitment of a PhD Student in the Social Science of COVID-19

We are searching for a PhD candidate interested in helping support an epidemiological sub-study of a new US-funded project. The SICA Study (Sero-epidemiological insight into COVID-19 transmission in Africa) is exploring the transmission of COVID-19 in the DRC and Nigeria. It is a 5-year project funded by the US CDC. The overarching hypothesis of the …

Recruitment of a PhD Student in the Social Science of COVID-19 Read More »

ACEGID Trains Rwandan Scientists in Next Generation Sequencing of SARS-CoV-2

ACEGID facilitated a three-week training on SARS-CoV-2 sequencing and bioinformatics for Rwandan scientists at the Rwanda Biomedical Centre (RBC). The training was held as a collaboration between ACEGID and RBC from January 31 to February 18, 2022. ACEGID scientists trained participants in the principles and practices of SARS-CoV-2 sequencing steps including sample handling, extraction, amplification, …

ACEGID Trains Rwandan Scientists in Next Generation Sequencing of SARS-CoV-2 Read More »

Sentinel Selected for Scale-up Support by Paris Peace Forum

Sentinel, our project focused on developing a pandemic pre-emption and response system, has received another boost as it was selected for scale-up support at the just concluded fourth edition of Paris Peace Forum (PPF). Out of 80 projects that were showcased at the global event, Sentinel was one of the ten projects that will benefit …

Sentinel Selected for Scale-up Support by Paris Peace Forum Read More »

ACEGID Strengthens National Capacity for Analysis…

PRESS RELEASE: ACEGID Strengthens National Capacity for Analysis of SARS-CoV-2 Data EDE, NIGERIA, August 17, 2021 The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) has started an intensive hands-on bioinformatics workshop on the analysis of SARS-CoV-2 genomic and contextual data. The two-weeks training aims to equip scientists from 11 public health laboratories …

ACEGID Strengthens National Capacity for Analysis… Read More »

Detection of SARS-CoV-2 P681H Spike Protein Variant in ACEGID Lab, Nigeria.

As viruses replicate and transfer from person to person, changes (mutations) can occur in these viruses. These mutations can lead to new variants of the virus being formed. Mutations can also either be a meaningless tweak or the virus alters itself in such a way that it can spread more easily and cause more infections. …

Detection of SARS-CoV-2 P681H Spike Protein Variant in ACEGID Lab, Nigeria. Read More »

ACEGID named as a Continental Reference Laboratory by WHO and Africa CDC

The World Health Organization (WHO) and the African Centre for Disease Control (Africa CDC) recently announced the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) as one of the three reference laboratories for the storage and analysis of the genomes of infectious diseases in Africa. This announcement came on the heels of effort …

ACEGID named as a Continental Reference Laboratory by WHO and Africa CDC Read More »